Literature DB >> 26563642

The expression of PLP/DM-20 mRNA is restricted to the oligodendrocyte-lineage cells in the adult rat spinal cord.

Kazuya Takeda1,2, Mari Dezawa1, Masaaki Kitada3.   

Abstract

Proteolipid protein (PLP) is the major component of myelin; its gene encodes two major splicing variants: PLP and DM-20. Compared with PLP, DM-20 lacks the amino acids encoded by exon IIIb. The expression of PLP/DM-20 in cells outside the oligodendrocyte-lineage is unclear. To address this issue, we analyzed the detailed expression pattern of PLP/DM-20 mRNA in the adult rat spinal cord by in situ hybridization (ISH) with a cRNA probe complementary to DM-20 mRNA, which has been used to detect both PLP and DM-20 both mRNA. ISH did not label the cells expressing NeuN nor glial fibrillary acidic protein but detected those expressing Olig2, indicating that PLP/DM-20 mRNA are expressed only in oligodendrocyte-lineage cells. This cell population was expected to contain NG2-expressing oligodendrocyte precursor cells (OPCs), because some exhibited the expression of glutathione S-transferase pi isoform in the nucleus. A recent publication showed that OPCs express PLP but not DM-20 mRNA. However, no OPCs were detected. We performed ISH with a cRNA probe that specifically recognizes PLP mRNA to successfully detect some OPCs. Additionally, OPCs were detected by ISH with a cRNA probe complementary to DM-20 mRNA that was digested via alkaline hydrolysis prior to ISH. These findings collectively demonstrate that PLP and DM-20 mRNA expression is restricted to oligodendrocyte-lineage cells, and imply that the undigested cRNA probe complementary to the full-length DM-20 mRNA sequence only recognizes DM-20 mRNA and not the PLP counterpart when applied to ISH without denaturation/digestion methods.

Entities:  

Keywords:  DM-20; Immunohistochemistry; In situ hybridization; Oligodendrocyte differentiation; Oligodendrocyte precursor cells; Proteolipid protein

Mesh:

Substances:

Year:  2015        PMID: 26563642     DOI: 10.1007/s00418-015-1384-5

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  52 in total

1.  Immunofluorescence staining of astrocytes in vitro using antiserum to glial fibrillary acidic protein.

Authors:  D S Antanitus; B H Choi; L W Lapham
Journal:  Brain Res       Date:  1975-05-23       Impact factor: 3.252

2.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

3.  Expression of the APC tumor suppressor protein in oligodendroglia.

Authors:  R V Bhat; K J Axt; J S Fosnaugh; K J Smith; K A Johnson; D E Hill; K W Kinzler; J M Baraban
Journal:  Glia       Date:  1996-06       Impact factor: 7.452

4.  Purification and immunohistochemical localization of rat brain myelin proteolipid protein.

Authors:  H C Agrawal; B K Hartman; W T Shearer; S Kalmbach; F L Margolis
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

5.  Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons.

Authors:  E R Bongarzone; C W Campagnoni; K Kampf; E C Jacobs; V W Handley; V Schonmann; A T Campagnoni
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

6.  A quantitative analysis of the development of the pyramidal tract in the cervical spinal cord in the rat.

Authors:  T G Gorgels; E J De Kort; H T Van Aanholt; R Nieuwenhuys
Journal:  Anat Embryol (Berl)       Date:  1989

7.  A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain.

Authors:  F A Tansey; W Cammer
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

Review 8.  Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection.

Authors:  Wiebke Möbius; Julia Patzig; Klaus-Armin Nave; Hauke B Werner
Journal:  Neuron Glia Biol       Date:  2009-06-05

9.  The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.

Authors:  Keith L Ligon; John A Alberta; Alvin T Kho; Jennifer Weiss; Mary R Kwaan; Catherine L Nutt; David N Louis; Charles D Stiles; David H Rowitch
Journal:  J Neuropathol Exp Neurol       Date:  2004-05       Impact factor: 3.685

Review 10.  Oligodendrocyte wars.

Authors:  William D Richardson; Nicoletta Kessaris; Nigel Pringle
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

View more
  4 in total

1.  Regulation of DM-20 mRNA expression and intracellular translocation of glutathione-S-transferase pi isoform during oligodendrocyte differentiation in the adult rat spinal cord.

Authors:  Masaaki Kitada; Kazuya Takeda; Mari Dezawa
Journal:  Histochem Cell Biol       Date:  2016-02-26       Impact factor: 4.304

2.  Diversity of developing peripheral glia revealed by single-cell RNA sequencing.

Authors:  Ozge E Tasdemir-Yilmaz; Noah R Druckenbrod; Olubusola O Olukoya; Weixiu Dong; Andrea R Yung; Isle Bastille; Maria F Pazyra-Murphy; Austen A Sitko; Evan B Hale; Sébastien Vigneau; Alexander A Gimelbrant; Peter V Kharchenko; Lisa V Goodrich; Rosalind A Segal
Journal:  Dev Cell       Date:  2021-08-31       Impact factor: 13.417

3.  Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey F Thompson; Victor M Salayandia; Melissa Cossé; Limor Raz; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  Neurobiol Dis       Date:  2018-02-24       Impact factor: 5.996

4.  Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.

Authors:  Kathrin Kaehler; Hartwig Seitter; Adolf M Sandbichler; Bettina Tschugg; Gerald J Obermair; Nadia Stefanova; Alexandra Koschak
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.